BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 12494875)

  • 1. The in vivo DNA aneuploidization during expansion of conventional renal cell carcinoma.
    Li G; Cottier M; Sabido O; Gentil-Perret A; Lambert C; Passebosc-Faure K; Genin C; Tostain J
    In Vivo; 2002; 16(5):341-4. PubMed ID: 12494875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo aneuploidization during the expansion of renal adenocarcinoma.
    Di Capua Sacoto C; Budia Alba A; Alapont Alacreu JM; Ruiz Cerda JL; Jimenez Cruz JF
    Urol Int; 2011; 86(4):466-9. PubMed ID: 21546757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA ploidy is a valuable predictor for prognosis of patients with resected renal cell carcinoma.
    Abou-Rebyeh H; Borgmann V; Nagel R; Al-Abadi H
    Cancer; 2001 Nov; 92(9):2280-5. PubMed ID: 11745282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA content in renal cell carcinoma. A clinical study with special reference to tumor heterogeneity and prognosis.
    Ljungberg B
    Scand J Urol Nephrol Suppl; 1986; 100():1-47. PubMed ID: 3472340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA cytophotometry in renal cell carcinoma: a significant prognostic factor?
    Feil G; Mittermüller B; Bichler KH; Wunderer A; Wechsel HW; Nelde HJ; St Krause F
    Anticancer Res; 1999; 19(2C):1483-6. PubMed ID: 10365128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA ploidy pattern in papillary renal cell carcinoma. Correlation with clinicopathological parameters and survival.
    del Vecchio MT; Lazzi S; Bruni A; Mangiavacchi P; Cevenini G; Luzi P
    Pathol Res Pract; 1998; 194(5):325-33. PubMed ID: 9651945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparison of flow cytometric, static cytometry and tumor cytogenetic investigation results human renal cell carcinomas].
    Krech RH; Baretton G; Fonatsch C; Diebold J; Früchtnicht W; Löhrs U
    Verh Dtsch Ges Pathol; 1990; 74():228-32. PubMed ID: 1708590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flow cytometric analysis of DNA-aneuploidy subgroups and proliferation in renal cell carcinoma.
    Schafhauser W; Liedl T; Elsässer D; Zörcher T; Schrott KM
    Anticancer Res; 1999; 19(2C):1471-5. PubMed ID: 10365126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA ploidy status and DNA content instability within single tumors in renal cell carcinoma.
    Bringuier PP; Bouvier R; Berger N; Piaton E; Revillard JP; Perrin P; Devonec M
    Cytometry; 1993; 14(5):559-64. PubMed ID: 8354129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flow cytometric DNA and cytomorphometric analysis in renal cell carcinoma: its correlation with histopathology and prognosis.
    Yu DS; Hsu CM; Lee WH; Chang SY; Ma CP
    J Surg Res; 1993 Nov; 55(5):480-5. PubMed ID: 8231166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant interferon alpha therapy in renal cell carcinoma (RCC): prognostic value of DNA cytophotometry.
    Basting R; Corvin S; Händel D; Hinke A; Schmidt D
    Anticancer Res; 1999; 19(2C):1493-5. PubMed ID: 10365130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ten-year results of a prospective study on the prognostic role of ploidy in endometrial carcinoma: dNA aneuploidy identifies high-risk cases among the so-called 'low-risk' patients with well and moderately differentiated tumors.
    Susini T; Amunni G; Molino C; Carriero C; Rapi S; Branconi F; Marchionni M; Taddei G; Scarselli G
    Cancer; 2007 Mar; 109(5):882-90. PubMed ID: 17262824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bcl-2 protein and DNA ploidy in renal cell carcinoma: do they affect patient prognosis?
    Skolarikos A; Alivizatos G; Bamias A; Mitropoulos D; Ferakis N; Deliveliotis C; Dimopoulos MA
    Int J Urol; 2005 Jun; 12(6):563-9. PubMed ID: 15985079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship of the 1 alpha, 25-dihydroxyvitamin D3 receptor concentration and the DNA content in renal cell carcinomas.
    Trydal T; Bakke A; Aksnes L; Aarskog D
    Anticancer Res; 1989; 9(6):1951-5. PubMed ID: 2560627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor spread and DNA content in human renal cell carcinoma.
    Ljungberg B; Stenling R; Roos G
    Cancer Res; 1988 Jun; 48(11):3165-7. PubMed ID: 3365699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fine needle aspiration biopsy of renal cell carcinoma. Cytologic parameters and their concordance with histology and flow cytometric data.
    Cajulis RS; Katz RL; Dekmezian R; el-Naggar A; Ro JY
    Acta Cytol; 1993; 37(3):367-72. PubMed ID: 8498138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of uPA, PAI-1, and DNA content in adult renal cell carcinoma.
    Chautard D; Dalifard I; Chassevent A; Guyetant S; Daver A; Vielle B; Soret JY
    Urology; 2004 Jun; 63(6):1055-60. PubMed ID: 15183949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Flow cytometric analysis of renal cell carcinoma].
    Lü GH
    Zhonghua Zhong Liu Za Zhi; 1990 Jan; 12(1):27-9. PubMed ID: 2364867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of DNA ploidy status in patients with rectal cancer.
    Berczi C; Bocsi J; Bartha I; Math J; Balazs G
    Anticancer Res; 2002; 22(6B):3737-41. PubMed ID: 12552986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of clinicopathologic and deoxyribonucleic acid flow cytometric variables in non-metastatic renal cell carcinoma in the modern era.
    Clark PE; Veys JA; Eskridge MR; Woodruff RD; Hall MC
    Urol Oncol; 2005; 23(5):328-32. PubMed ID: 16144666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.